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Abstract
Background: The European Union Training Mission Mali (EUTM MLI) is a multinational military training deployment
to the Western African tropical nation of Mali. Based on routinely collected disease and non-battle injury
surveillance data, this study quantifies the true impact of infectious diseases for this tropical mission and potential
seasonal variations in infectious disease threats.
Methods: Categorized health events during the EUTM MLI mission and associated lost working days were reported
using the EpiNATO-2 report. Infection-related health events were descriptively analyzed for a 4-year period from the
12th week in 2013 to the 13th week in 2017. Aggregated EpiNATO-2 data collected from all missions other than
EUTM MLI were used as a comparator.
Results: Among the infectious diseases reported by EUTM MLI, non-severe upper respiratory infections and
gastrointestinal diseases dominated quantitatively, accounting for 1.65 and 1.42 consultations per 100 person-
weeks, respectively. The number of recorded infectious disease-associated lost working days during the whole
study interval was 723. Seasonal changes in disease frequency were detectable. More gastrointestinal infections
were seen in the rainy season, and more respiratory infections occurred in the dry season; these were associated
with peaks of more than 2.5 consultations per 100 person-weeks for both categories.
Conclusions: Despite initial concerns focused on tropical infectious diseases during this mission in tropical Mali,
upper respiratory tract and gastrointestinal infections predominate. The relatively low number of reported lost
working days may indicate that these infections are at the milder end of the spectrum of infectious diseases
despite a likely reporting bias.
Keywords: Tropical deployment, Infectious diseases, Tropical medicine, Gastrointestinal infections, Upper respiratory
tract infections, Mali
Background
In 2013, the European Training Mission in Mali (EUTM
MLI) was initiated to support the military training of the
Malian Armed Forces. EUTM MLI is a relatively small
mission with less than 1000 European soldiers deployed
to the topical environment of the south of the Republic
of Mali. The aim of the mission is military on-site train-
ing of the armed forces of Mali. The military medical
infrastructure comprises a role 1 unit at the mission
headquarters in the capital Bamako and a role 2 unit at
the major training site in Koulikoro.
General assumptions about the threat to the deployed
force from tropical diseases and the general lack of reliable
surveillance data in conflict areas led to the deployment of
experts in tropical medicine and infectious diseases as part
of the in-theatre medical support package at the beginning
of the mission. Further, in collaboration with the Deploy-
ment Health Surveillance Capability (DHSC) of the
NATO Centre of Excellence for Military Medicine, the
health of the force deployed to EUTM MLI has been
monitored continuously by using the EpiNATO-2 weekly
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surveillance report. This has been in place since the begin-
ning of the mission.
EpiNATO-2 is the current and only interoperable illness
and injury surveillance system within the Alliance. It has
been in use since the twelfth calendar week of 2013, and
EUTM MLI was one of the two early adopters of the sys-
tem. The prospective EpiNATO-2 data collection is rou-
tinely analyzed by DHSC to provide timely information to
the deployed commander about trends in illness and in-
jury. Providers can report laboratory-confirmed disease in
their weekly reports; however, the limited spectrum and
availability of rapid near-patient diagnostics means that
the focus of EpiNATO-2 is to monitor clinically diagnosed
disease.
The authors are unaware of any contemporary pub-
lished reports of prospective cohort data describing the
epidemiology and burden of communicable infectious
diseases in military personnel deployed to West Africa.
Despite reconnaissance, the scarcity of available epi-
demiological data meant that a comprehensive causality
estimate was not conducted prior to the mission. The
health threats to travelers is well described in previous
assessments [1–4], including some tailored for military
audiences [5]. Tropical infectious diseases predominate,
a finding reinforced in case reports of outbreaks, medical
repatriations, and illnesses in returning travelers. In a
French assessment of soldiers medically repatriated from
Africa, Plasmodium falciparum malaria was by far the
most frequent diagnosis [6]. Malaria was also identified
as a major cause of severe infections during British
deployments to Western African Sierra Leone [7–9].
The French army even reported one or two fatal courses
of malaria per year on deployment [10].
EpiNATO-2 data collection provides a potential means
of addressing this gap in knowledge. These data,
together with occasional point prevalence assessments
[11, 12], allow for a more realistic estimation of the
actual burden of infectious disease threats. In this paper,
we describe the patterns of infectious disease threats
reported in EUTM MLI and relate this to a microbio-
logical assessment of routinely collected food samples.
Methods
Data collection
The medical facilities in Bamako, Mali (role 1) and Kou-
likoro, Mali (role 2), reported consultations by military
personnel deployed to the EUTM MLI mission weekly
using the EpiNATO-2 illness and injury surveillance re-
port. The surveillance method is described in detail
within STANAG 2535 (Standardization Agreement),
AMedP-4.1 (Allied Medical Publication) Deployment
Health Surveillance, NATO 2017.
EpiNATO-2 monitors ambulatory care first atten-
dances that can be categorized into one or more of 17
specified illness and injury events labelled Alpha through
Quebec. These events were selected by a multinational
expert panel for their relevance in terms of impact on
operational effectiveness. A further non-specific event
labelled Romeo is used to monitor unusual or excep-
tional events. All of the categorized events together with
Table 1 Communicable infectious diseases monitored by EpiNATO-2
Event serial and name Definition
Alpha – gastrointestinal illness (GI infections) All diagnoses consistent with upper or lower digestive tract infection. Includes any type of
diarrhea, gastroenteritis, “stomach flu”, “food poisoning”, nausea/vomiting, etc. Excludes non-
infectious intestinal diagnoses such as hemorrhoids, ulcers, hernias, etc., and chronic condi-
tions such as irritable bowel syndrome
Bravo – upper respiratory tract infection (URTI) Acute upper respiratory infections of the ear, nose and throat. Includes “common cold”,
tonsillitis, otitis, sinusitis, isolated acute laryngitis and tracheitis. Excludes acute laryngitis and
tracheitis associated with an influenza-like illness (map to Item 4-Delta influenza-like illness
and lower respiratory tract infection ILI). Excludes allergic or irritant conditions (if necessary,
map to Item 18-Romeo unusual or exceptional event)
Delta - Influenza-like illness and lower respiratory tract
infection (Flu symptoms and LRTI)
Illness characterized by fever (central temperature > 38.5 °C or > 101.3 °F) and either cough
or sore throat, associated or not with laryngitis and tracheitis. Includes pneumonia and
bronchitis
Echo – fever of unknown origin (Unexplained fever) Central temperature > 38.5 °C or 101.3 °F, or history of chills and fever without a clear
diagnosis. Such fever cannot be explained by other inflammatory or infectious processes
such as respiratory infections, heat, or overexertion. Includes septicemia and viremia
Foxtrot – hemorrhagic illness Acute systemic illness characterized by fever, chills, back pain or generalized myalgia and
varying hemorrhagic manifestations such as bleeding gums, epistaxis, hematemesis, melena,
metrorrhagia, strawberry tongue, disseminated intravascular coagulation, petechiae or
bruising; consistent with viral hemorrhagic fever (VHF). Excludes biologically confirmed
diagnosis of VHF – map to A.7 notifiable infectious diseases reporting
Hotel – acute neurological disorders Acute infection or intoxication of the central nervous system (CNS). Includes meningitis,
encephalitis, or encephalopathy and acute non-specific symptoms such as meningism and
delirium. Excludes alcohol intoxication or any chronic, hereditary, or degenerative conditions
of the CNS such as obstructive hydrocephalus, Parkinson’s, and Alzheimer’s.
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any other first and follow-up attendances are also sum-
marized in a catch-all count of total consultations.
The clear majority of communicable infectious diseases
are monitored using the 6 specified events described in
Table 1 below. These are intended to monitor clinical diag-
nosis only. Where some form of laboratory confirmation is
available, including rapid diagnostics, the case is reported in
a notifiable infectious disease report. This provides a count
of cases only and does not replace national notification pro-
cedures. Given that the primary source of surveillance data
is from the outpatient role 1 medical treatment facilities,
DHSC believes that almost all incident infectious disease is
captured in the illness and injury surveillance report.
It is likely that several cases of infectious disease will
have been classified into other categories. For example,
event Juliet is used to report dermatological disorders,
and this includes fungal infections, cellulitis, and infesta-
tions. Furthermore, event Lima is used to report dental
disorders that will include dental infections. A detailed
study of cases reported in these events is needed to de-
termine the proportion of reported cases that could be
considered communicable.
Fig. 1 Results of data assessment and exclusion of records
Fig. 2 Most commonly reported reasons for new medical consultations during the study interval for EUTM MLI
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It is also possible that some cases of infectious disease
will be reported in event Romeo as an unusual or excep-
tional event. These cases should normally have an ac-
companying missive; however, very few accompanying
notes have been received by DHSC. This and the afore-
mentioned are limitations of the data collection, and the
potential effect is under-estimation of the true commu-
nicable infectious disease burden. Notwithstanding, we
believe that the 6 categories above capture the lion’s
share of incident communicable infectious diseases.
Loss of productivity due to incident illness and injury
in each of the specified events is a part of the
EpiNATO-2 data collection. This is measured using lost
working days (LWD), which is the sum of the days of
complete exclusion from duties for all patients in a given
specified event. Partial exclusions from duties are not
monitored. In addition, there is no standardized way of
prescribing exclusion from duties. Analysis published
elsewhere [13] has shown heteroskedasticity or no obvi-
ous correlation between LWD and count of attendance
where one might be expected a priori; therefore, the in-
terpretation of these data is limited.
Data collected using the EpiNATO-2 format since ISO
calendar week 12 of 2013 through calendar week 13 of
2017 is included in the analysis. Since week 14 of 2017,
the EpiNATO-2 report from EUTM MLI has changed be-
cause of the publication of a new version of STANAG
2535. Broadly speaking, the changes simplify the language
used in the original versions, and the intent is for future
data to remain comparable with the past. The more
significant changes were to remove event Romeo and add
specified categories so that first attendances are now cate-
gorized exhaustively and to delete the reporting of LWD.
On deployment, the EpiNATO-2 data were certified
by the role 1 physicians in charge. Physicians were pro-
vided with standard operating procedures by the theatre
HQ (headquarters), which included reporting timelines,
the definitions, and a reporting template. On a weekly
basis, data were sent to the Medical Force Health Pro-
tection officer of the respective mission for a final
consistency check. Afterwards, the data were forwarded
to the DHSC for analysis and feedback of findings.
To assess potential differences with other deployments
during the same assessment period, the data from EUTM
MLI were compared with the aggregated EpiNATO-2 data
collected from all other assessed operations being sur-
veyed by DHSC. This includes operations in Kosovo,
Afghanistan, Sierra Leone, Iraq, and the standing NATO
maritime groups patrolling the Mediterranean.
Data assessment
The EpiNATO-2 reports included in the analysis were
inspected to assess completeness and validity. Records
were excluded if they were missing the number of
personnel at risk, were missing all specified illness and
injury events, or if the total number of consultations re-
ported (which should include new and follow-ups) was
less than the sum of the reported new cases of specified
event categories. Figure 1 shows the results of the
Fig. 3 Variation in the crude rate of reported disease categories year by year for EUTM MLI
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exclusion process. There were, however, no options to
assess the completeness of entries in the databases.
Microbiological real-life data from a hygiene screening in
the canteen
As an etiological correlate of the observed gastrointestinal
infections, the results from a microbiological assessment
from a hotel canteen where EUTM MLI personnel
regularly ate are presented as an example. The analysis was
provided as an illustration to discuss practical implications
of syndromic real-time surveillance. For this assessment,
the analysis was restricted to qualitative assessment of bac-
terial growth due to the long transport and storage time of
samples, which did not allow quantitative analysis.
Due to the expectation of inadequate storage and
transport conditions on deployment, samples were taken
Fig. 4 Variation in reported infectious disease events by category and year for EUTM MLI. Seasonal variation in new consultation rates by year (4-
week rolling rates, reported infectious diseases only)
Fig. 5 Variation in reported specific infectious diseases events by calendar week for EUTM MLI. Seasonal variation in new consultation rates by
event (4-week rolling rates, reported infectious diseases only)
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with gel swabs (product number 80.1661.500, Sarstedt,
Nümbrecht, Germany) to support the viability of bac-
teria. After swabbing, storage and transport of approxi-
mately three days at room temperature prior to delivery
to a diagnostic laboratory in Germany was unavoidable
due to logistic limitations. As quantitative assessment
was not feasible under such poor pre-analytic conditions
making considerable die-off of microorganisms likely
[14], only qualitative assessment was deemed possible.
Therefore, the swabs were incubated in non-selective
thioglycolate broth (Oxoid, Wesel, Germany) at 36 °C
for 24 h. Afterwards, culture and isolation were per-
formed on non-selective Columbia sheep-blood agar
(Oxoid) with subsequent differentiation and resistance
testing using a VITEK II laboratory automate.
Ethics
An ethical clearance was not considered necessary for
this assessment, which is in line with national laws and
regulations. The reason is that no personal-confidential
data are presented, only case numbers provided by a
super-national health authority and data from a micro-
biological assessment, which did not include any human
samples.
Results
Data sets assessed during the study interval
The total denominator of the data collected during this
interval was 1,148,565 person-weeks prior to applying
the exclusion criteria. After excluding all records acco-
rding to the criteria described above, 112,279
person-weeks for EUTM MLI and 957,341 for
non-EUTM missions remained. For EUTM MLI there
were 9805 new consultations reported using the
EpiNATO-2 categories; 282 reports used category Ro-
meo and thus were considered unusual or exceptional
events. However, there was very little information about
the underlying diseases of the Romeo incidents in the
Table 2 Comparison of aggregated rates of EpiNATO-2 infectious disease events reported by EUTM MLI compared with non-EUTM
missions
EpiNATO-2 event Difference between EUTM and non-EUTM missions (%) 95% CI Chi squared df P value
GI infections 0.9376 0.8677–1.0100 1519.222 1 < 0.0001
URTI 0.6661 0.5896–0.7449 425.692 1 < 0.0001
Flu symptoms and LRTI 0.1219 0.0968–0.1447 62.136 1 < 0.0001
Unexplained fever 0.0627 0.0297–0.0933 12.895 1 0.0003
Hemorrhagic illness 0.1800 0.0026–0.0088 0.593 1 0.4412
Acute neurological disorders 0.1293 0.1064–0.1547 377.100 1 0.0001
Other events 1.8967 1.7633–2.0323 1084.692 1 0.0001
GI Gastrointestinal, URTI Upper respiratory tract infections
Fig. 6 Lost working days during the study interval for EUTM MLI. Lost working days reported by event and by year
Frickmann et al. Military Medical Research  (2018) 5:19 Page 6 of 11
database. Accordingly, new cases and lost working days
reported using this category were excluded from any fur-
ther analysis.
Descriptive assessment of the infectious disease-related
categories
The most commonly reported reasons for new consulta-
tions during the assessment period are shown in Fig. 2.
The non-infectious diseases widely dominated, followed
by URTI and GI infections. The number of cases over
the study interval (and crude rate per person-week) of
reported infectious disease-associated disease categories
were as follows: GI infections: 1599 (1.42 per 100
person-weeks), URTI: 1858 (1.65 per 100 person-weeks),
flu symptoms and LRTI: 148 (0.13 per 100
person-weeks), unexplained fever: 80 (0.25 per 100
person-weeks), hemorrhagic illness: 8 (0.01 per 100
person-weeks), and acute neurological disorders: 180
(0.16 per 100 person-weeks).
Figure 3 shows the variation in the crude rate of reported
health events year by year. Over all assessed periods, the
quantitative dominance of the URTI and GI infection
events remained stable.
Figure 4 demonstrates the seasonal variation in the
4-week rolling average of the crude rate of reported in-
fectious disease events, with the dashed line showing the
pooled data over the whole study interval. The rate var-
ied between slightly less than 2.5 and 5.0 consultations
per 100 person-weeks with a slightly higher rate in the
second half of the year with particularly pronounced oc-
currence at the end of the rainy season in summer. The
values for CW 38 and 47 (2013), 9 (2014) and 40 (2015)
were missing and therefore interpolated by calculating
and rounding down the average of the values for the
week before and the week after the missing values.
When making assessments on a category level, it be-
comes obvious that most of the variation is due to
reporting of the URTI and GI infection events. The con-
tribution of the categories to overall seasonal variation
in infectious diseases reporting is shown in Fig. 5. While
there is a marked increase in diarrhea in the rainy sum-
mer time, upper respiratory tract infections are more
common in the dry season in winter.





Enterococci Further potentially harmful species
Cut papaya fruit from the breakfast buffet Negative Negative Positive Pseudomonas aeruginosa
Cut watermelon from the breakfast buffet Negative Negative Positive Enterobacter cloacae ssp. cloacae
Tomatoes in the hotel kitchen Positive Negative Positive ESBL-positive Klebsiella oxytoca, Acinetobacter spp.
Apples in the hotel kitchen Positive Negative Negative Enterobacter cloacae ssp. cloacae
Cut cabbage in the hotel kitchen Negative Negative Negative Pseudomonas aeruginosa, Klebsiella pneumoniae
Handle of the big refrigerator in the hotel
kitchen
Negative Negative Positive Aeromonas hydrophila/caviae
Cutting machine of the hotel kitchen Negative Negative Positive Delftia acidovorans, Acinetobacter pittii
Cutting plate of the hotel kitchen Positive Negative Positive Enterobacter cloacae ssp. cloacae, Klebsiella
pneumoniae
Flour from a working place in the bakery Negative Negative Negative Klebsiella oxytoca, Enterobacter cloacae ssp. cloacae
Red chili sauce from the lunch buffet Negative Negative Negative Enterobacter cloacae ssp. cloacae,
Acinetobacter ursingii
White rice from the lunch buffet Negative Negative Negative Pantoea agglomerans
Cut carrots from the lunch buffet Negative Negative Positive Acinetobacter pittii,
Aeromonas hydrophila/caviae,
Kluyvera cryocrescens
Cold chicken salad from lunch Negative Positive Positive Aeromonas hydrophila/caviae,
Enterobacter ludwigii
Cake as a dessert from lunch Negative Negative Negative Klebsiella pneumoniae,
Enterobacter cloacae ssp. cloacae,
Klebsiella oxytoca
Paprika salad from the dinner buffet Negative Positive Positive Pseudomonas aeruginosa,
Proteus spp.
Mayonnaise salad from the dinner buffet Negative Negative Positive Pseudomonas aeruginosa,
Proteus spp.
Olives from the dinner buffet Negative Negative Positive Bacillus cereus var. mycoides,
Proteus spp.
Frickmann et al. Military Medical Research  (2018) 5:19 Page 7 of 11
Visual inspection suggests the rate of infectious dis-
eases reported by EUTM MLI was consistently higher
than for other missions (Additional file 1: Figures S1 and
S2). Table 2 shows the results of the comparison of pro-
portions using the “N-1”Chi-square test and confirms
that there is significantly higher reporting of infectious
diseases by EUTM MLI compared to the pooled rate for
all non-EUTM missions. Compared with respiratory in-
fections, gastrointestinal infections play only a minor
role in non-EUTM theatres. The crude rate of reported
infectious disease events on non-EUTM missions varied
between slightly more than 1 and slightly more than 2
consultations per 100 person-weeks (Additional file 1:
Figure S3), and there was no pronounced peak in the
months of autumn. Focusing on disease categories, there
is a slight increase in URTI events in the autumn and
winter time and there are no marked variances for the
other assessed categories (Additional file 1: Figure S4).
The number of lost working days by disease category
is shown in Fig. 6. During the whole study interval, a
total of 1837 lost working days has been reported for
EUTM MLI. The number of reported lost working days
declined from 4.4 per 100 person-weeks in 2013 to 0.93
per 100 person-weeks in 2017. There is no explanation
for the decline in reported lost working days.
Of the reported lost working days, 700 were due to an
infectious disease of the category GI infection (0.62 per
100 person-weeks). The second most common cause of
lost working days was event category URTI, which con-
tributed 205 lost working days (0.18 per 100
person-weeks). Given that the surveillance data source is
ambulatory care consultations, the figures are likely to
be an underestimate of the true impact in terms of loss
of productivity. EpiNATO-2 does not monitor duration
of hospital admissions or strategic aeromedical evacua-
tions. Further investigation of this type of healthcare ac-
tivity data may provide a better understanding of the
true level of loss of productivity.
Notifiable infectious diseases and events
Synchronized with the weekly EpiNATO-2 data collection,
medical treatment facilities are required to submit a report
of cases of infectious diseases where there is supportive or
confirmatory laboratory evidence. This includes the
results of rapid diagnostic tests deployed in the theatre.
Reports of confirmed diseases in EUTM MLI during
the study period are summarized in Additional file 1:
Figure S5. The most common disease reported was mal-
aria; however, the average number of cases during the en-
tire study was only 0.02 per 100 person-weeks. The key
limitation of these data is the lack of ascertainment of
cases diagnosed following repatriation or after assessment
of samples by national reference laboratories.
Microbiological real-life data from a hygiene screening in
the canteen
As the GI infection category was the main reason for lost
working days due to infectious diseases, a microbiological
assessment of the restaurant of the hotel, where the EUTM
MLI headquarter was deployed, was conducted in the 4th
quarter of the year 2015. The results are shown in Table 3.
Fecal contamination could be non-quantitatively confirmed
for both the provided food and for equipment and the in-
frastructure of the kitchen. Potentially disease-related mi-




This assessment was performed to quantify the infec-
tious disease burden during the EUTM MLI mission to
allow a rational risk assessment for this tropical deploy-
ment. Tropical infectious diseases were considered a
major health threat to the deployed personnel. Micro-
biological onsite surveillance data from EUTM MLI are
scarce. In response to repeated complaints on the fre-
quent occurrence of acute diarrhea episodes during this
mission, a diagnostic surveillance was performed from
December 2013 to August 2014 on this issue. Diarrhea-
genic Escherichia coli and noroviruses were identified as
the most frequent causative agents, while invasive bac-
teria and protozoa were less frequent [11], and the dis-
eases usually responded well to short-term antibiotic
therapies with rifaximin, ciprofloxacin or azithromycine.
Of note, considerable beta-lactame resistance in local
Escherichia coli strains was observed as a side
phenomenon [12].
To allow a broader assessment, clinical diagnosis sur-
veillance data is presented in this study. Among the regis-
tered infectious diseases, there was a marked quantitative
dominance of upper respiratory tract infections and
gastrointestinal infections. The reporting of infectious dis-
eases confirmed by laboratory results was very low and, of
those reported, malaria was the most common.
An obvious seasonal variance, potentially associated with
the shift of the dry season to the rainy season and vice
versa, was only detectable for upper respiratory tract infec-
tions and gastrointestinal infections as well. One might
speculate that the conditions during the rainy seasons
might have facilitated both bacterial growth on warm moist
surfaces, smear-associated pathogen transmission and
spoiling of food, resulting in more diarrhea during this
period, although underlying mechanisms are still poorly
understood [15]. In contrast, the dry season in Mali is asso-
ciated with winter season in Europe, when upper respira-
tory tract infections are more frequent [16]. The increased
influx of disease aligns with changes in the mucous mem-
branes during the dry season in Mali, as dry mucous
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membranes become further dehydrated by air-conditioning
systems in the dry, hot weather. If there is poor mainten-
ance for air-conditioning systems, they might further con-
tribute to the spread of upper-respiratory disease by
whirling up pathogens from contaminated filters; in
addition, the associated cooling of the nasal airway may be
a facilitating factor, as previously discussed [17].
Interestingly, the number of lost working days due to in-
fectious diseases was disproportionately lower than the ac-
tual number of cases. This might indicate a strong
dominance of infections with low severity. Alternatively,
the fact that the number of lost working days is consider-
ably lower than the total number of health events reported
may suggest underreporting. The marked decrease in the
number of lost working days over the years, for which no
specific reason was detectable, might support this hypoth-
esis. It is also likely that lost working days were incom-
pletely ascertained as the surveillance system does not
monitor hospital admissions or strategic evacuation.
The low number of lost working days is also in contra-
diction with previous experience from other missions.
The British, for example, reported an average of 2.8 lost
working days per person due to gastrointestinal infec-
tions during operation HERRICK in Afghanistan [18].
Such comparisons make underreporting and incomplete
ascertainment likely. However, to the authors’ experience
from EUTM MLI, GI episodes were usually mild and
did not necessarily result in exclusion from duty. To re-
duce nosocomial spread, strict precautions regarding
basic and toilet hygiene were enforced that allowed the
patients to remain on duty. Other than in battle opera-
tions, the physical efforts during the training mission in
Mali were usually negligible, so operability of the forces
could be maintained despite low-impact infections.
Therefore, low numbers of lost working days due to mild
infections is not basically implausible, although incom-
plete reporting is likely to contribute to the low numbers
of recorded lost working days.
In comparison with other deployments in the assess-
ment period, the proportion of gastrointestinal infections
is markedly increased for the EUTM MLI mission. The
total proportions of infectious diseases are increased as
well and, more than this, no seasonal changes were ob-
served for the averaged non-EUTM missions.
The strong dominance of gastrointestinal infections
among the lost working days due to infectious causes cor-
relates well with fecal contamination as observed in the
food provided by the restaurant of the hotel where the
headquarter of EUTM MLI was deployed. Long transport
and storage time of samples did not allow a quantitative
assessment of pathogens, an undeniable limitation. In fact,
the analysis was not performed to deduce justiciable con-
sequences from the results but, instead, to get a crude es-
timation on the physical presence or absence of potential
pathogens and fecal contamination in a quantity being
sufficient to allow for cultural detection even despite inad-
equately long storage and transport time. Due to these
modest demands, basically inacceptable deviations, both
from national screening standards and the standards by
the Codex Alimentarius of the World Health
Organization, were accepted due to reduced logistic op-
tions that were mission-associated. Although the assess-
ment led to some infrastructure changes in the kitchen of
the restaurant, the effects of these procedures remained
questionable, and a control assessment could not have
been performed for logistic reasons. A change from food
consumption in the hotel to definitely safe food sources
such as military field rations was avoided for operational
reasons, although the safety of military field rations was
confirmed by previous diarrhea surveillance in Mali,
where no diseased individual had consumed only such ra-
tions [11]. The operational reasons included the need for
joint food consumption together with the local allies in
their local infrastructure in Mali during meetings for most
of the soldiers from the headquarters. Accordingly, a
step-wise adaptation to local hygiene conditions and
food-associated contamination seemed advisable to miti-
gate associated health-related consequences in the inter-
mediate term [19]. Further, consumption of local food
outside the camp could not have been suppressed due to
relatively free movements of the soldiers as part of the
mission policy. Accordingly, a baseline diarrhea rate that
remained within ranges that seemed acceptable to the
military mission command and did not lead to unaccept-
ably high numbers of lost working days was tolerated [19].
Among the overwhelming proportion of non-severe
infectious diseases, the identification of severe cases po-
tentially requiring immediate action may be a challenge
for the field doctor in charge and requires constant
awareness during tropical deployment. In line with this,
there was no hint for a detectable increase of disease
categories suggesting severity, for example, severe re-
spiratory tract infections, fever, hemorrhage and neuro-
logical disorders, in the rainy season. Therefore, the
attentiveness for such events requires the same level
during the whole year. Fortunately, there have been no
hints for a high frequency so far. As stated above, un-
usual or exceptional events of the category Romeo were,
however, not included in the assessment due to poor
available data.
Despite the obviously low severity of the frequently de-
tected gastrointestinal and respiratory infections, their cal-
culated therapy remains challenging due to a broad
differential diagnostic spectrum. This could be shown by
surveillance on diarrhea-associated pathogens in the same
mission [11]. Broad spectrum antibiotic drugs such as
macrolides and fluoroquinolones have shown good effects
despite this differential diagnostic uncertainty, as previously
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demonstrated [20–22] and documented in guidelines [23,
24]. However, broad spectrum antibiotic drugs are likely to
support the selection of multidrug resistant bacteria [25].
Information on the local resistance situation was scarce,
although point prevalence assessments suggested an abun-
dance of ESBL-positive Enterobacteriaceae [12]. Fortu-
nately, respective transient colonization of the soldiers’ gut
seems to be of short duration, and the enteric carrier rate
of German soldiers with ESBL-positive strains at 8–
12 weeks after deployment is low [26].
Solutions for the field doctor should include
low-threshold availability of options for infectious dis-
ease diagnostics in theatre [27] and sustained enforce-
ment of basic hygiene procedures for military field
camps in the tropics.
Limitations of the study comprise potentially varying
qualifications and motivations of the field doctors who
had to enter the EpiNATO-2 data. Although this source
of bias is difficult to quantify, it might explain phenom-
ena such as the low documented number of lost working
days. Thus, database entries were vulnerable to random
errors. More than this, syndromic surveillance is poorly
suited to identify minor changes of rare but potentially
severe diseases. Other sources of information, such as
reports from aeromedical repatriation, are more likely to
identify the frequency of rare but severe diseases such as
those demonstrated by other groups [28, 29]. However,
aeromedical repatriation is in the national responsibility.
Accordingly, respective data were not available for this
super-national assessment, and a respective analysis
would have been beyond the scope of this work. Finally,
data from syndromic surveillance can only represent ill
soldiers who present to medical care. For low impact
health conditions, individuals may treat themselves
instead of seeking medical care, resulting in underre-
porting, as suggested by others based on troop surveys
[18, 30, 31].
Conclusions
Although infectious diseases are frequent during the
EUTM MLI mission in tropical Mali, the infections mainly
comprise non-severe gastrointestinal and respiratory dis-
eases. The associated number of lost working days is low;
however, this is likely to be due to incomplete ascertain-
ment and under-reporting. The quantitative proportions of
flu symptoms and lower respiratory tract infections, unex-
plained fever, hemorrhagic illness, and acute neurological
disorders were very low compared to gastrointestinal infec-
tions and upper respiratory tract infections. This suggests
that an in-theatre specialist in tropical infectious diseases
may not be required and a generalist or community phys-
ician is adequate; however, the field doctor would still need
support in the form of reach back to this type of subject
matter expertise. Near-patient diagnostic tools may
facilitate the differential diagnosis for the field doctor in
charge. Notwithstanding, the reinforcement of basic field
hygiene and sanitation measures is still relevant now, as it
always has been, in military field camps on tropical
deployments.
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